19018-Lung Cancer-NA-468

Lung Cancer

516-005: A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Therapy (SAPPHIRE)

  • Details

ClinicalTrials.gov ID: NCT03906071
Diagnosis Type: NA
USOR Number:

  • Address

5050 NE Hoyt St, Suite 256
Portland, OR 97213
P: (503) 239-7767

Search by practice name, trial titles, indicators and specific disease types.

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.